Functionalized mesoporous silica nanoparticles as delivery systems for doxorubicin: Drug loading and release

Abstract

Functionalized nanoparticles have played a major role in the field of targeted therapy, owing to their ability to control the release and for the selective delivery of entrapped materials to tumours. In this work, we described the loading capacity and in vitro release kinetics of mesopo-rous silica nanoparticles (MSNs), functionalized with Poly‐L‐Histidine and Tamoxifen. The model drug Doxorubicin (DOX) was successfully encapsulated into MSN‐based systems, using the technique of solvent immersion. A post‐surface grafting loading method was investigated on func-tionalized systems, with DOX loading content determined using HPLC. Dialysis bag diffusion was employed to investigate the release kinetics of DOX‐loaded‐systems at pH 7.4 and 5. The amount of DOX released from native MSNs systems over a 72 h period at pH 5 was approximately 40%; and at pH 7.4 ≈ 30%. A moderate pH dependent release behaviour was observed with both our function-alized systems: DOX@MSN‐PLH and DOX@MSN‐PLH‐TAM; with approximately 5% of DOX released from DOX@MSN‐PLH‐TAM at pH 7.4 and about 9% released at pH 7.4 over 72 h. The maximal cumulated release of DOX molecules from DOX@MSN‐PLH after 72 h was ≈ 18% at pH 7.4 and ≈ 23% at pH 5, respectively. The outcome of this work offers a promising contribution towards building future stimuli‐responsive nano‐drug delivery systems.